OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Tathiane M. Malta, Artem Sokolov, Andrew J. Gentles, et al.
Cell (2018) Vol. 173, Iss. 2, pp. 338-354.e15
Open Access | Times Cited: 1754

Showing 26-50 of 1754 citing articles:

Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity
Brooke Prinzing, Caitlin C. Zebley, Christopher T. Petersen, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 620
Open Access | Times Cited: 207

Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer
Zhao Zhang, Joo‐Hyung Lee, Hang Ruan, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 205

ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer
Guotai Xu, Sagar Chhangawala, Emiliano Cocco, et al.
Nature Genetics (2020) Vol. 52, Iss. 2, pp. 198-207
Open Access | Times Cited: 182

Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11
Xinbo Wang, Yueqing Chen, Xudong Wang, et al.
Cancer Research (2021) Vol. 81, Iss. 20, pp. 5217-5229
Open Access | Times Cited: 182

Cancer Stemness Meets Immunity: From Mechanism to Therapy
Peiwen Chen, Wen‐Hao Hsu, Jincheng Han, et al.
Cell Reports (2021) Vol. 34, Iss. 1, pp. 108597-108597
Open Access | Times Cited: 181

Machine learning and clinical epigenetics: a review of challenges for diagnosis and classification
Sebastian Rauschert, Kyle Raubenheimer, Phillip E. Melton, et al.
Clinical Epigenetics (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 176

EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures
Suhas Vasaikar, Abhijeet Deshmukh, Petra den Hollander, et al.
British Journal of Cancer (2020) Vol. 124, Iss. 1, pp. 259-269
Open Access | Times Cited: 171

Recent Progress of Stem Cell Therapy in Cancer Treatment: Molecular Mechanisms and Potential Applications
Dinh‐Toi Chu, Tiep Tien Nguyen, Nguyen Le Bao Tien, et al.
Cells (2020) Vol. 9, Iss. 3, pp. 563-563
Open Access | Times Cited: 165

N-Myc–mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer
Adeline Berger, Nicholas J. Brady, Rohan Bareja, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 9, pp. 3924-3940
Open Access | Times Cited: 159

Single cell transcriptomics of primate sensory neurons identifies cell types associated with chronic pain
Jussi Kupari, Dmitry Usoskin, Marc Parisien, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 151

Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological Malignancies
Nikolas G. Balanis, Katherine M. Sheu, Favour N. Esedebe, et al.
Cancer Cell (2019) Vol. 36, Iss. 1, pp. 17-34.e7
Open Access | Times Cited: 149

An integrative ENCODE resource for cancer genomics
Jing Zhang, Donghoon Lee, Vineet K. Dhiman, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 141

Cancer Stem Cell Plasticity – A Deadly Deal
Archana P. Thankamony, Kritika Saxena, Reshma Murali, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 139

Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling
Qianxi Yang, Shaorong Zhao, Zhendong Shi, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 131

A modular master regulator landscape controls cancer transcriptional identity
Evan Paull, Àlvaro Aytés, Sunny J. Jones, et al.
Cell (2021) Vol. 184, Iss. 2, pp. 334-351.e20
Open Access | Times Cited: 109

Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness
Yize Li, T. Mamie Lih, Saravana M. Dhanasekaran, et al.
Cancer Cell (2022) Vol. 41, Iss. 1, pp. 139-163.e17
Open Access | Times Cited: 108

Integrated Machine Learning and Bioinformatic Analyses Constructed a Novel Stemness-Related Classifier to Predict Prognosis and Immunotherapy Responses for Hepatocellular Carcinoma Patients
Dongjie Chen, Jixing Liu, Longjun Zang, et al.
International Journal of Biological Sciences (2021) Vol. 18, Iss. 1, pp. 360-373
Open Access | Times Cited: 104

Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good, the Bad and the Beauty
Cédric Badowski, Bing He, Lana X. Garmire
npj Precision Oncology (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 103

Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set
Hengrui Liu, Tao Tang
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 87

The journey from melanocytes to melanoma
Patricia P. Centeno, Valeria Pavet, Richard Marais
Nature reviews. Cancer (2023) Vol. 23, Iss. 6, pp. 372-390
Closed Access | Times Cited: 85

METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability
Huafu Li, Chunming Wang, Linxiang Lan, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 80

Fatty acid metabolism reprogramming in ccRCC: mechanisms and potential targets
Sze Kiat Tan, Helen Y. Hougen, Jaime R. Merchan, et al.
Nature Reviews Urology (2022) Vol. 20, Iss. 1, pp. 48-60
Closed Access | Times Cited: 78

Scroll to top